November 24, 2021
The Ministry of Health, Labor and Welfare (MHLW) on November 22 granted orphan drug designation to three APIs including Daiichi Sankyo’s valemetostat tosilate. Valemetostat tosilate earned the status for the expected indication of relapsed/refractory adult T-cell leukemia-lymphoma. The two other...read more